Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I dont like to say anything negative about D|EST as I hold shares. But FFS, a strategic review? What a load of @:%! . Thery are a small company with 24 employees. Just make a decision and go with it. And for trial redesign? It seems like a total shambles who designed the first trial? bob the builder? I still think this could be big, but lets have some information on why startup of the trial is taking so long. Have they made any submissions to get the trial approved yet? And they are supposed to fund the trial without diluting the shares? How does that work? These people need to pull their fingers out....
With regard to yesterday I feel although the presentation was good they basically have shot themselves in the foot by announcing a strategic review. They realistically should have done the review before the results, there was no need to announce it, by doing that yesterday they're basically saying they can't get a deal based on the present credentials because any companies they have been in consultation with have deemed Phase 3 costs too expensive.
The positives are the cash which they have but the negatives are that how long will the review take? It's very amiss of Tovey to not give shareholders a timeline, that is a red flag. Not investable at the present, maybe when the review is done and we know further.
I was hoping a rabbit could be pulled out of the big top hat but all that came out were some promissory notes for 2025.
When CT was appointed he was revered as the new Paul Daniels, well the school report has just come out and the headmaster has noted what he has produced, the answer being "not a lot"
As in the case of Neil Woodford the former now disgraced fund manager who was the darling of the stock market, past success is no guarantee of future glory. I am sure CT is probably just as unhappy as the pi's but the big promises are just that at the moment. We all know money is in short supply for bio's so a company has to produce something startling to gain traction. Dest has a lot going for it but it needs more meat on the bones to get that elusive deal, that'll take much longer, the market doesn't like waiting, that's why they are where they are with the sp.
My earlier post on 15th April has proved me right, more kicking of the can, cannot get a deal that satisfies the company, nearly two years now! CT may be happy with the progress but his appointment hasn't exactly been a light bulb moment.
"That was before that terrible rns. Everybody had high hopes the back end of last year then JW sold and all hell broke loose. CT released that rns which compounded the issue and it's been downhill ever since. Most people inc me expected a deal at the latest Jan '24 but because the rns stated that phase 2 trial might have to be done again people started to be scared and started to sell. CT has not done anything to address people's worries, that says to me the discussions with the companies with a view to a good deal is not forthcoming.
If in the eventuality Dest has to go it alone for the phase 3 trial then a large fund raise will be necessary, that is why the sp is where it is.
They say no news is good news but in this case it's the reverse. Most people's stop losses have been taken out inc mine at 32p which I have stated. If good news happens then I will be back, we all await the update next week to see where the land lies but I fear it will be more kicking the can down the road with promises of a future deal. The market will not like that and the sp could drop further to around 10p. My views which I have said before are that Dest could go private or go on the Nasdaq. To drop from 80p down to this level shows a lack of communication from the board to address people's concerns.
When CT was appointed with Sir Nigel coming back as well everyone thought it was a slam dunk but unfortunately it hasn't worked out as yet and my fear is it won't. GL all, alamo🤘😎"
No fear do you mean the only way is down?
The only way now is UP!
Up or down :)
I have good feeling this will fly tommrow!
....the sp is where it is considering the results tomorrow.....could be a bit of a bloodbath, tin hat time as that can is ripe for the kicking unless CT pulls a rabbit out of the hat.
GL all, alamo🤘😎